0001209191-22-019254.txt : 20220316
0001209191-22-019254.hdr.sgml : 20220316
20220316164412
ACCESSION NUMBER: 0001209191-22-019254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220315
FILED AS OF DATE: 20220316
DATE AS OF CHANGE: 20220316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ahmadzai David
CENTRAL INDEX KEY: 0001813060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12537
FILM NUMBER: 22745429
MAIL ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC.
CENTRAL INDEX KEY: 0000708818
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
IRS NUMBER: 952888568
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
BUSINESS PHONE: 404-467-1500
MAIL ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20100804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-15
0
0000708818
NEXTGEN HEALTHCARE, INC.
NXGN
0001813060
Ahmadzai David
3525 PIEDMONT RD., NE
BUILDING 6, SUITE 700
ATLANTA
GA
30305
0
1
0
0
Chief Accounting Officer
Common Stock
2022-03-15
4
M
0
3250
16.37
A
47772
D
Common Stock
2022-03-15
4
M
0
3000
16.83
A
50772
D
Common Stock
2022-03-15
4
S
0
6250
19.5525
D
44522
D
Stock Option (right to buy)
16.37
2022-03-15
4
M
0
3250
0.00
D
2025-06-13
Common Stock
3250
6000
D
Stock Option (right to buy)
16.83
2022-03-15
4
M
0
3000
0.00
D
2026-06-01
Common Stock
3000
3000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.55 to
$19.561. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders
upon request.
Original grant of 13,000 options granted on 6/13/2017 vested in four equal, annual installments beginning 6/13/2018.
Original grant of 12,000 options granted on 5/30/2018 vests in four equal, annual installments beginning 6/1/2019. Options exercised vested on 6/1/2021. Remaining 3,000 options will vest on 6/1/2022.
/s/ Jeffrey D. Linton, Attorney-in-Fact for David Ahmadzai
2022-03-16